Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | COR | ARGX |
|---|---|---|
| Price | $311.56 | $955.32 |
| Change today | ▼ 0.23% | ▲ 1.00% |
| Market cap | $59.45B | $59.77B |
| Return, 3 months | +9.7% | +12.1% |
| Return, year to date | -7.2% | +13.6% |
| Return, 1 year | +1.8% | +30.9% |
| P/E (TTM) | 23.1 | 36.4 |
| P/B | 19.5 | 7.1 |
| P/E percentile vs own 5y | 51st | 85th |
| Dividend yield | 0.75% | – |
| Revenue growth (YoY, latest qtr) | +5.1% | +59.6% |
| Net profit growth (YoY) | +12.6% | +91.9% |
| Gross margin | 4.0% | 90.0% |
| Operating margin | 1.4% | 30.7% |
| Net margin | 0.8% | 32.8% |
| Return on equity | 104.3% | 23.6% |
| Analyst target vs. price | +19.8% | +23.4% |
| Analyst buy share | 75% | 95% |
| RSI (14) | 50 | 43 |
| 30-day volatility | 28.0% | 51.2% |
| Max drawdown, 1 year | -32.4% | -28.6% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.